Resurgence of seasonal influenza driven by A/H3N2 and B/Victoria in succession during the 2023–2024 season in Beijing showing increased population susceptibility
Journal of Medical Virology · 2024-06 · 96 (6)
DOI: 10.1002/jmv.29751 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 17.06.2024. Verfasst von Wentao Zhu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Clinical Microbiology, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medica…. Hauptthemen laut MEDLINE: Influenza, Human, Influenza B virus, Seasons, Influenza A Virus, H3N2 Subtype. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Golden Seed Program of Beijing Chaoyang Hospital (CYJZ202220).
Abstract (Originalsprache)
During the COVID‐19 pandemic, non‐pharmaceutical interventions were introduced to reduce exposure to respiratory viruses. However, these measures may have led to an “immunity debt” that could make the population more vulnerable. The goal of this study was to examine the transmission dynamics of seasonal influenza in the years 2023–2024. Respiratory samples from patients with influenza‐like illness were collected and tested for influenza A and B viruses. The electronic medical records of index cases from October 2023 to March 2024 were analyzed to determine their clinical and epidemiological characteristics. A total of 48984 positive cases were detected, with a pooled prevalence of 46.9% (95% CI 46.3–47.5). This season saw bimodal peaks of influenza activity, with influenza A peaked in week 48, 2023, and influenza B peaked in week 1, 2024. The pooled positive rates were 28.6% (95% CI 55.4–59.6) and 18.3% (95% CI 18.0–18.7) for influenza A and B viruses, respectively. The median values of instantaneous reproduction number were 5.5 (IQR 3.0–6.7) and 4.6 (IQR 2.4–5.5), respectively. The hospitalization rate for influenza A virus (2.2%, 95% CI 2.0–2.5) was significantly higher than that of influenza B virus (1.1%, 95% CI 0.9–1.4). Among the 17 clinical symptoms studied, odds ratios of 15 symptoms were below 1 when comparing influenza A and B positive inpatients, with headache, weakness, and myalgia showing significant differences. This study provides an overview of influenza dynamics and clinical symptoms, highlighting the importance for individuals to receive an annual influenza vaccine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Diseases and Clinical Microbiology, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, P.R. China.
ORCID-Profile: Wentao Zhu
Förderung
- Golden Seed Program of Beijing Chaoyang Hospital (CYJZ202220)
Zitieren
APA
Zhu, W., & Gu, L. (2024). Resurgence of seasonal influenza driven by A/H3N2 and B/Victoria in succession during the 2023–2024 season in Beijing showing increased population susceptibility. Journal of Medical Virology, 96(6). https://doi.org/10.1002/jmv.29751
Vancouver
Zhu W, Gu L. Resurgence of seasonal influenza driven by A/H3N2 and B/Victoria in succession during the 2023–2024 season in Beijing showing increased population susceptibility. Journal of Medical Virology. 2024;96(6). doi:10.1002/jmv.29751
BibTeX
@article{Zhu2024,
author = {Zhu, Wentao and Gu, Li},
title = {Resurgence of seasonal influenza driven by A/H3N2 and B/Victoria in succession during the 2023–2024 season in Beijing showing increased population susceptibility},
journal = {Journal of Medical Virology},
year = {2024},
volume = {96},
number = {6},
doi = {10.1002/jmv.29751}
}
EUVIMED